Articles
It’s all about access, stupid

It’s all about access, stupid

Expectations of Med Comms agencies are evolving and these days it’s as much about delivering the audience as it is the content. How then, Chris Stevenson asks, can they step up their game in order to deliver to these higher expectations? Many of us will remember the mantra from Presidential candidate Bill Clinton some years ago when asked what the…

Articles
A way to mitigate outsourcing risk?

A way to mitigate outsourcing risk?

There is much to gain from out sourcing, with careful planning and due consideration to potentials risks. Anthony Walker and Robert Johnson discuss how to select an appropriate outsourcing strategy and minimize the business risk. Many firms that outsource major projects can end up managing relationships at arms length. For complex, business-critical projects, this is…

Articles
Seeking winning solutions in the new NHS

Seeking winning solutions in the new NHS

As the UK forges ahead with decentralising power back to the GPs, pharmaphorum interviews Stephen Turley to understand how pharma can embrace the change. The UK government is implementing radical changes to the NHS that will decentralise the decision-making powers back to local GP consortia…

Sales & Marketing

Sales & Marketing
Solution Spotlight: BrandPRO Biopharma
Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Digital

Market Access

Editor's Picks

  1. UK budget includes £1bn biopharma investment package
  2. HHS doubles down on controversial peptides plan
  3. Lilly's triple G overpowers Ozempic in diabetes trial
  4. UK puts £100m into "world-first" AI biosecurity facility
  5. US gives $99m for Ebola jab project, as cases spread in Africa

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more